Show simple item record

Induction of hyperinsulinemia and hyperglycemia in dogs by administration of diabetogenic bovine pituitary peptide

dc.contributor.authorLouis, Lawrence H.en_US
dc.contributor.authorConn, Jerome W.en_US
dc.contributor.authorAppelt, Mary M.en_US
dc.date.accessioned2006-04-17T16:29:00Z
dc.date.available2006-04-17T16:29:00Z
dc.date.issued1971-03en_US
dc.identifier.citationLouis, Lawrence H., Conn, J. W., Appelt, Mary M. (1971/03)."Induction of hyperinsulinemia and hyperglycemia in dogs by administration of diabetogenic bovine pituitary peptide." Metabolism 20(3): 326-330. <http://hdl.handle.net/2027.42/33697>en_US
dc.identifier.urihttp://www.sciencedirect.com/science/article/B6WN4-4C4WCCR-C4/2/aaffe7fe3d372c1a39471d81a91793cfen_US
dc.identifier.urihttps://hdl.handle.net/2027.42/33697
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=5546927&dopt=citationen_US
dc.description.abstractA peptide exhibiting diabetogenic and anti-insulin properties isolated from bovine adenohypophysis was administered subcutaneously in single doses to four dogs for 2 to 3 consecutive days. Ten hours after each injection, the animals were given an oral glucose load and a series of blood samples were obtained for glucose and insulin determinations. In one dog, the procedure was repeated 13 days after the first one. In another animal, the same procedure was carried out three times. Glucose tolerance was clearly impaired and serum insulin rose excessively in three of the four animals. In the fourth animal the response was observed but only after the third injection. Thus, insulin resistance appears to be a major mechanism by which this peptide induces loss of carbohydrate tolerance.en_US
dc.format.extent373903 bytes
dc.format.extent3118 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherElsevieren_US
dc.titleInduction of hyperinsulinemia and hyperglycemia in dogs by administration of diabetogenic bovine pituitary peptideen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelMedicine (General)en_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumMetabolism Research Unit, University of Michigan Medical School, Ann Arbor, Mich., USA; Department of Internal Medicine, Division of Endocrinology and Metabolism, University of Michigan Medical School, Ann Arbor, Mich., USAen_US
dc.contributor.affiliationumMetabolism Research Unit, University of Michigan Medical School, Ann Arbor, Mich., USA; Department of Internal Medicine, Division of Endocrinology and Metabolism, University of Michigan Medical School, Ann Arbor, Mich., USAen_US
dc.contributor.affiliationumMetabolism Research Unit, University of Michigan Medical School, Ann Arbor, Mich., USA; Department of Internal Medicine, Division of Endocrinology and Metabolism, University of Michigan Medical School, Ann Arbor, Mich., USAen_US
dc.identifier.pmid5546927en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/33697/1/0000209.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1016/0026-0495(71)90117-Xen_US
dc.identifier.sourceMetabolismen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.